#kras

[ follow ]
#cancer-research #drug-development #clinical-trials #mutant-proteins #pancreatic-cancer #galectin-1
Cancer
fromNature
1 week ago

New drugs take aim at one of cancer's deadliest mutations

Researchers are developing innovative strategies to target the cancer-causing KRAS protein, previously deemed 'undruggable', showing promising results in clinical trials.
Science
fromNature
4 months ago

Six highlights from pancreatic cancer research

Nuclear galectin-1 in stromal fibroblasts drives KRAS expression, sustaining fibroblast activation and promoting pancreatic tumour growth; targeting intracellular and extracellular Gal-1 offers therapeutic potential.
[ Load more ]